WO2002062416A1 - Apparatus for dispensing powdered material - Google Patents

Apparatus for dispensing powdered material Download PDF

Info

Publication number
WO2002062416A1
WO2002062416A1 PCT/GB2002/000553 GB0200553W WO02062416A1 WO 2002062416 A1 WO2002062416 A1 WO 2002062416A1 GB 0200553 W GB0200553 W GB 0200553W WO 02062416 A1 WO02062416 A1 WO 02062416A1
Authority
WO
WIPO (PCT)
Prior art keywords
tube
powdered material
repository
dip tube
wall
Prior art date
Application number
PCT/GB2002/000553
Other languages
French (fr)
Inventor
Michael H. James
Original Assignee
Nasaleze Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0103172A external-priority patent/GB0103172D0/en
Application filed by Nasaleze Limited filed Critical Nasaleze Limited
Priority to EP02711035A priority Critical patent/EP1368090B1/en
Priority to US10/467,773 priority patent/US7465287B2/en
Priority to DE60219442T priority patent/DE60219442T2/en
Publication of WO2002062416A1 publication Critical patent/WO2002062416A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A45HAND OR TRAVELLING ARTICLES
    • A45DHAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D33/00Containers or accessories specially adapted for handling powdery toiletry or cosmetic substances
    • A45D33/02Containers or accessories specially adapted for handling powdery toiletry or cosmetic substances with dispensing means, e.g. sprinkling means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0021Mouthpieces therefor
    • A61M15/0025Mouthpieces therefor with caps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/08Inhaling devices inserted into the nose
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05BSPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/04Deformable containers producing the flow, e.g. squeeze bottles
    • B05B11/042Deformable containers producing the flow, e.g. squeeze bottles the spray being effected by a gas or vapour flow in the nozzle, spray head, outlet or dip tube
    • B05B11/045Deformable containers producing the flow, e.g. squeeze bottles the spray being effected by a gas or vapour flow in the nozzle, spray head, outlet or dip tube designed for spraying particulate material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/06Containers or packages with special means for dispensing contents for dispensing powdered or granular material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/07General characteristics of the apparatus having air pumping means
    • A61M2205/071General characteristics of the apparatus having air pumping means hand operated
    • A61M2205/075Bulb type

Definitions

  • the present invention relates to apparatus for dispensing a restricted or regulated amount of powdered material and component parts. Apparatus of this type are particularly useful in the delivery of powdered material to the human nasal tract.
  • powdered materials both pharmaceutically active and non- pharmaceutically active
  • Talcum powders are put on the skin to make it feel smooth or to help it stay dry.
  • a number of anti-fungal treatments, for both plants and animals, are dispensed in powdered form, i.e. powdered preparations for "athletes foot”. Powders are delivered to the lungs or nasal membrane in the form of a spray or an aerosol for a number of therapeutic purposes.
  • any pharmaceutically active component of a powder administered in this way can take effect quickly as, unlike with oral preparations, there is no need for it to be absorbed via the gastrointestinal tract before being transported to the lungs or nasal cavity.
  • these techniques allow 'first-pass' effects to be avoided and, thirdly, since the powder is applied at the site where it is required, their use reduces the systemic dosage of active agent (when present) and, hence, any risk of undesirable side effects.
  • powdered material can also be delivered to the nose or lungs as a means of conveying an active agent directly to the blood stream.
  • Powdered materials are often delivered to the lungs or nasal membranes in the form of a spray or an aerosol produced by an inhaler or like device.
  • inhaler device There are several main types of inhaler device currently available on the market. These include metered dose inhalers and the devices sold under the trademarks Diskhaler® and Rotahaler®.
  • metered dose inhalers the powder for delivery is contained in a pressurised canister and activating a valve on the canister causes a defined amount of the powder to be released in a jet of propellant gas.
  • Diskhalers® accept magazines, each in the form of a blister pack in which each blister contains an individual dose consisting of a defined amount of powder. To operate the device, the user must align a loaded blister within the device, pierce it to release the powder and then suck the released powder into his lungs.
  • Rotahalers® are similar, but accept single capsules of powder.
  • Diskhalers® and Rotahalers® require a plurality of manipulations in order not only to load them, but also to have them release a pre-measured quantity of material, before it is available for inhalation by the user.
  • the level of manual dexterity required to use these devices makes them particularly unsuited to use by the very young, infirm, handicapped and old.
  • the effective use of a metered dose inhaler requires an ability to co-ordinate inhalation with valve actuation that is beyond the capacity of many potential users, particularly the very young.
  • a deformable bottle contains some powdered material and houses a dip tube. Squeezing the sides of the bottle, by opposing fingers, increases the internal pressure of the bottle when compared to atmospheric pressure resulting in an airflow that is channelled out of the bottle through the dip tube. This airflow entrains the powdered material, releasing a restricted amount of the powdered material from the bottle.
  • the powder is hydroxypropylmethylcellulose, an inert cellulose powder.
  • the powder When delivered into the nasal cavity it immediately turns to a gel-like material as it reacts with the moisture present in the nasal tract. This gel is able to replicate the properties of real mucus and as such is able to alleviate, prevent or ultimately stop a hayfever or asthma attack.
  • Epithelial cells lining the nasal tract contain a secretion called mucus, which accumulates in the cells giving them a distended and goblet-shaped appearance. Eventually, the goblet cells burst releasing the mucus, which as well as protecting the nasal membranes from mechanical and chemical injury also prevents inhaled particles from reaching the delicate alveoli of the lungs. Allergens entrained in air inhaled into the nasal tract, alight on the mucus present therein, whereby, because of the mucus's low surface tension, they are immediately adsorbed. The shape of the nasal tract causes a "smoke ring" effect to occur so that dust, dirt, pollen etc.
  • hydroxypropylmethylcellulose to the nasal cavity, in order to mimic mucus, does not require a precise dosage as the compound is pharmaceutically inert.
  • an unrestricted delivery of the powder may cause an uncomfortable blockage of the nasal cavity and may even result in difficulty in breathing through the nose.
  • delivery of amounts of the powdered material that exceeds a volume that is required for the powder to be effective is wasteful and therefore unduly costly.
  • apparatus for dispensing a restricted amount of powdered material comprising a repository for powdered material, an outlet and a passageway defined between the repository and the outlet, wherein a volume of air can be propelled through powdered material resting in the repository, thereby entraining powdered material, and carry powdered material thus entrained along the passageway and out of the apparatus in an upwardly direction, via the outlet.
  • a restriction in the passageway regulates the amount of powdered material delivered.
  • a conduit extends between the repository and the outlet, and defines the restriction.
  • an entrance to the conduit is defined within the repository and said restriction is disposed at said entrance.
  • the restriction is produced by a gap defined between said entrance and a wall of the repository.
  • the conduit can comprise a tube with an open end in substantial abutment with a wall of the repository and the restriction can be provided by an opening in the wall of said tube. The opening can be in the form of one or more notches in the open end of the tube.
  • the conduit comprises a tube arranged for length wise insertion into the repository and to displace powdered material from its path transversely to said insertion.
  • the conduit comprises a tube having a wall including a portion with a length wise tapered cross-sectional area.
  • the cross-sectional perimeter of a portion of the tube can be tapered in a length wise direction.
  • the cross-sectional area of a portion of the lumen defined by the tube can taper in a length wise direction.
  • the cross-sectional area of the tube wall tapers towards an open end of the tube located within the repository.
  • the open end can be in the form of an annular knife edge.
  • the tube can be sealed to the repository excepting an opening, or openings, in its wall.
  • the apparatus is arranged for the delivery of powdered material into a nasal cavity, this is preferably possible wherein the outlet forms a nozzle for insertion into a nostril.
  • the conduit is a dip tube.
  • Apparatus in accordance with the invention may dispense powdered material for the treatment of a medical condition, preferably for the treatment of allergic rhinitis or asthma and preferably wherein the powdered material is hydroxypropylmethylcellulose .
  • a further aspect of the invention is a conduit for use in the apparatus as described above.
  • a dip tube for use in apparatus for dispensing a restricted amount of powdered material, wherein the dip tube is arranged for length wise insertion into a repository and to displace powdered material from its path transversely to said insertion.
  • the dip tube comprises a tube having a wall including a portion with a length wise tapered cross-sectional area.
  • the cross-sectional perimeter of a portion of the tube can be tapered in a length wise direction.
  • the cross-sectional area of a portion of the lumen defined by the tube can taper in a length wise direction.
  • the cross-sectional area of the tube wall tapers towards an open end of the tube located within the repository.
  • the open end can be in the form of an annular knife.
  • the tube can be sealed to the repository excepting an opening, or openings, in its wall.
  • a dip tube is arranged for the delivery of powdered material into a nasal cavity, this is preferably possible wherein the outlet forms a nozzle for insertion into a nostril.
  • a dip tube in accordance with the invention may dispense powdered material for the treatment of a medical condition, preferably for the treatment of allergic rhinitis or asthma wherein the powdered material is preferably hydroxypropylmethylcellulose .
  • Figure 1 shows a side plan view (side B), and section thereof (side A), of a nasal delivery apparatus in accordance with the invention
  • Figure 2 shows a side plan view (side A), and sectional view thereof (side B), of a dip tube in accordance with the invention
  • Figure 3 shows a side plan view (side A), and a sectional view thereof (side B), of a dip tube in accordance with the invention
  • Figure 4 shows a side plan view (side A), and a sectional view thereof (side B), of a dip tube in accordance with the invention.
  • Apparatus in accordance with the invention is shown in Figure 1 and comprises a cap 1 and a bottle 2, formed from a thermal plastic material such as polyvinylchloride, housing a dip tube 3, and provides a repository for a quantity of powdered material 4.
  • the cylindrical bottle 2 comprises a substantially cylindrical body portion 5, extending between a first end portion 6 and shoulder portion 7.
  • the first end portion 6 defines a flat closed disc end base of the bottle 2.
  • the bottle also comprises a neck portion 8, extending between the shoulder portion 7 and the second end portion 12 which defines an opening.
  • a first annular flange 9 extends radially outward from the neck portion 8 of the cylindrical bottle 2 and is releaseably sealed with a second annular flange 10 disposed on the cap 1, to form in use, a tamper proof safety seal as would be readily known to a man skilled in the art.
  • a first screw thread 11 commences at the first annular flange 9 and extends around and partway along the neck portion 8 of the cylindrical bottle 2 in the direction of the second end portion 12.
  • the dip tube 3 is inserted into the internal cavity 13 of the bottle 2 through the opening defined by the second end portion 12, sealing said opening defined by the second end portion 12 by acting as a stopper for the bottle.
  • the dip tube 3 comprises a hollow tube with a first opening 14 at one end, opening into the internal cavity 13.
  • the rim 15 defining the first opening 14 abuts with, or substantially abuts with, the internal surface of the first end portion 6.
  • a castellation 16 defines a notch in the side wall of the dip tube 3, said notch defined by the castellation being continuous with the first opening 14.
  • the second opening 17 is disposed at the tip of the nozzle portion 18 of the dip tube 3.
  • the nozzle portion 18 is a narrowed portion of the dip tube 3 such that it is dimentioned to fit up a nostril.
  • the dip tube 3 has a radial protrusion 21 which fits inside an indentation on the inner surface of the neck portion 8 of the bottle 2 to form a friction fit.
  • a further radial protrusion 20 on the dip tube 3 sits on top of the bottle neck to seal the bottle.
  • the cap 1 is shaped such that it may releasably retain the neck portion 8 and nozzle 18 within the cavity 23 when the devise is not in use.
  • first screw thread 11 co-operates with second screw thread 24, which is disposed on the internal surface of the cap 1.
  • the cap 1 has a friction surface 25 extending around a portion of external surface of the cap, for ease of rotation between opposing fingers during the operation of removing the cap 1 from the bottle 2.
  • Figure 2 shows a preferred embodiment of the dip tube 3.
  • Side B of the dotted line shows a section through the dip tube 3.
  • the dip tube 3 has a lumen 26 linking the first 14 and second 17 openings.
  • the inner wall 27 and outer wall 28 become gradually closer, graduations occur in the portion of the dip tube 3 that is disposed within the body portion 5 of the bottle 2.
  • This narrowing of the width of the wall results in a gradual reduction in the diameter of the dip tube 2 and an increase in the diameter of the lumen 26 within the dip tube 2.
  • the narrowest point of the tapering portion 22 defines the first opening 14.
  • the inner wall and the outer wall meet to form the rim 15 of the first opening 14.
  • the sectional profile of the rim 15 being rounded.
  • the inner and outer walls taper to the first opening 14 with an inner wall 27 and outer wall 28 meeting to form a sharp point at the rim 15 in sectioned profile.
  • the end of the tip tube 3, to be located in the internal cavity 13 is formed as if cut at an acute angle to the tube's axis and sealed with an eliptical end plate 29.
  • a first opening 14 is formed in the side wall of the dip tube 3 adjacent to the plate 29.
  • the cylindrical bottle 2 is filled with powered material 4.
  • a user should place the nozzle 18 defining the second end portion 12 of the dip tube 3 into a nostril and then squeeze the body portion 5 between opposing fingers.
  • the compression of the body portion 5 reduces the volume of the cylindrical bottle 2, thereby increasing internal pressure relative to atmospheric pressure. This results in a proportion of the air within the cylindrical bottle flowing down the pressure gradient and finding an exit by travelling through the castellation 16, up through the lumen 26 of the dip tube 3 and exiting at the second opening 17 into the nostril.
  • particles of the powered material 4 will become entrained therein.
  • the limited volume of the powder 4 that is capable of passage through castellation 16 whilst entrained in the air flow will be delivered to the nasal cavity.
  • the pressure gradient will be transient, as equilibrium will be re-established rapidly.
  • the transience of the air flow combined with the fact that the castellation 16 limits the amount of powered material 4 that is given passage to the lumen 26, results in a regulation of the powered material 4 that is capable of expulsion from the apparatus during a single compression of the body portion 5.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Nozzles (AREA)
  • Preliminary Treatment Of Fibers (AREA)
  • Air Transport Of Granular Materials (AREA)

Abstract

The invention relates to an apparatus for dispensing a restricted amount of powdered material, comprising a repository (2) for powdered material (4), an outlet (12), and a conduit (3). The apparatus defines an airway arranged to enable air to be drawn through the resting powdered material in the repository, thereby entraining the powdered material in the airflow and drawing the air and entrained powdered material through the conduit. The air and entrained powdered material is thereafter expelled out of the outlet. Additionally, the invention relates to a dip tube (3) for use in apparatus for dispensing a powdered material.

Description

APPARATUS FOR DISPENSING POWDERED MATERIAL
The present invention relates to apparatus for dispensing a restricted or regulated amount of powdered material and component parts. Apparatus of this type are particularly useful in the delivery of powdered material to the human nasal tract.
The dispensing of powdered materials, both pharmaceutically active and non- pharmaceutically active, is required for a number of uses. Talcum powders are put on the skin to make it feel smooth or to help it stay dry. A number of anti-fungal treatments, for both plants and animals, are dispensed in powdered form, i.e. powdered preparations for "athletes foot". Powders are delivered to the lungs or nasal membrane in the form of a spray or an aerosol for a number of therapeutic purposes.
The topical treatment of asthma, by the application of regulated amounts of powdered medicaments to the lungs, has become a well established practice. Although not so well established, it is also known to treat allergic rhinitis (hayfever) with powdered medicaments applied to the nasal membranes. So treating these and similar conditions can give rise to various advantages. Firstly, any pharmaceutically active component of a powder administered in this way can take effect quickly as, unlike with oral preparations, there is no need for it to be absorbed via the gastrointestinal tract before being transported to the lungs or nasal cavity. Secondly, these techniques allow 'first-pass' effects to be avoided and, thirdly, since the powder is applied at the site where it is required, their use reduces the systemic dosage of active agent (when present) and, hence, any risk of undesirable side effects.
As well as directly treating the epithelial cells lining the nose or lungs, powdered material can also be delivered to the nose or lungs as a means of conveying an active agent directly to the blood stream.
Powdered materials are often delivered to the lungs or nasal membranes in the form of a spray or an aerosol produced by an inhaler or like device. There are several main types of inhaler device currently available on the market. These include metered dose inhalers and the devices sold under the trademarks Diskhaler® and Rotahaler®. In the case of metered dose inhalers, the powder for delivery is contained in a pressurised canister and activating a valve on the canister causes a defined amount of the powder to be released in a jet of propellant gas. Diskhalers®, on the other hand, accept magazines, each in the form of a blister pack in which each blister contains an individual dose consisting of a defined amount of powder. To operate the device, the user must align a loaded blister within the device, pierce it to release the powder and then suck the released powder into his lungs. Rotahalers® are similar, but accept single capsules of powder.
Diskhalers® and Rotahalers® require a plurality of manipulations in order not only to load them, but also to have them release a pre-measured quantity of material, before it is available for inhalation by the user. The level of manual dexterity required to use these devices makes them particularly unsuited to use by the very young, infirm, handicapped and old. The effective use of a metered dose inhaler requires an ability to co-ordinate inhalation with valve actuation that is beyond the capacity of many potential users, particularly the very young.
The above discussed known devices are relatively complex pieces of apparatus, all of which include a number of intricate moving parts. This, in turn, makes them expensive to manufacture and easy to break. They are also sufficiently prone to clogging to require cleaning on a daily basis. However, they do have the advantage that they are able to dispense a predetermined dose.
Although simple devices for the delivery of powdered material exist, none are capable of restricting the level of powdered material that is dispensed. Such simple devices comprise a container for the powder and an amount of the powder to be dispensed, only loosely controlled by a simple hole, or a large gauze or open cell foam plug. In use, these devises are inverted and the powder allowed to freely flow downwards, doing little to restrict the flow of the powdered material. Such devices are adequate for dispensing non-pharmaceutically active compounds, or therapeutically active compounds with a wide therapeutic window, which do not require precise regulation of dosage, negating the need to use expensive and complexes devices described. These devices have the advantage that they are cheap to manufacture and easy to use. However, the amount of powder dispensed is not regulated which is wasteful and therefore unduly costly.
Additionally, as these devices must be inverted for the powdered material to be delivered, it is difficult to deliver the powder to the axilla, or orifices such as the nasal cavity. Where powder is to be delivered to the axilla, or the nasal cavity, one must adopt an uncomfortable position before inversion of the device, i.e. when delivering powder to the nasal cavity, the head must be bend backwards.
It is an object of the present invention to provide a simple apparatus which will regulate, to an extent, the amount of powder delivered, which improves upon apparatus already in use.
In an embodiment of the invention a deformable bottle contains some powdered material and houses a dip tube. Squeezing the sides of the bottle, by opposing fingers, increases the internal pressure of the bottle when compared to atmospheric pressure resulting in an airflow that is channelled out of the bottle through the dip tube. This airflow entrains the powdered material, releasing a restricted amount of the powdered material from the bottle.
In a preferred embodiment the powder is hydroxypropylmethylcellulose, an inert cellulose powder. When delivered into the nasal cavity it immediately turns to a gel-like material as it reacts with the moisture present in the nasal tract. This gel is able to replicate the properties of real mucus and as such is able to alleviate, prevent or ultimately stop a hayfever or asthma attack.
Epithelial cells lining the nasal tract contain a secretion called mucus, which accumulates in the cells giving them a distended and goblet-shaped appearance. Eventually, the goblet cells burst releasing the mucus, which as well as protecting the nasal membranes from mechanical and chemical injury also prevents inhaled particles from reaching the delicate alveoli of the lungs. Allergens entrained in air inhaled into the nasal tract, alight on the mucus present therein, whereby, because of the mucus's low surface tension, they are immediately adsorbed. The shape of the nasal tract causes a "smoke ring" effect to occur so that dust, dirt, pollen etc. is instantly separated out from and pushed to the periphery of the clear air left in the middle. This clean air is then able to enter the lungs while the mucus, which eventually drains out naturally through the digestive system, adsorbs the allergens. People who suffer with allergic rhinitis and asthma often have a reduced amount of mucus.
The dispensing of hydroxypropylmethylcellulose to the nasal cavity, in order to mimic mucus, does not require a precise dosage as the compound is pharmaceutically inert. However, an unrestricted delivery of the powder may cause an uncomfortable blockage of the nasal cavity and may even result in difficulty in breathing through the nose. Furthermore, delivery of amounts of the powdered material that exceeds a volume that is required for the powder to be effective, is wasteful and therefore unduly costly.
Accordingly, in a first aspect of the invention, there is provided apparatus for dispensing a restricted amount of powdered material, comprising a repository for powdered material, an outlet and a passageway defined between the repository and the outlet, wherein a volume of air can be propelled through powdered material resting in the repository, thereby entraining powdered material, and carry powdered material thus entrained along the passageway and out of the apparatus in an upwardly direction, via the outlet.
In a preferred embodiment a restriction in the passageway regulates the amount of powdered material delivered.
In a further preferred embodiment a conduit extends between the repository and the outlet, and defines the restriction. Preferably an entrance to the conduit is defined within the repository and said restriction is disposed at said entrance. More preferably, the restriction is produced by a gap defined between said entrance and a wall of the repository. The conduit can comprise a tube with an open end in substantial abutment with a wall of the repository and the restriction can be provided by an opening in the wall of said tube. The opening can be in the form of one or more notches in the open end of the tube.
It was noted during development of the apparatus in accordance with the invention, that during manufacture of the apparatus, insertion of the dip tube resulted in the compression of the powder beneath the flat surface of the rim at the end of the dip tube, ultimately resulting in a blockage of the airway and making it difficult to fully insert the dip tube. Effective insertion of the dip tube into the apparatus was only capable of being effected when the apparatus was on its side. Manufacture of the apparatus in this orientation is difficult as the powdered material may easily pour out of the apparatus, thus rendering the manufacturing process inefficient.
Therefore, In a further embodiment the conduit comprises a tube arranged for length wise insertion into the repository and to displace powdered material from its path transversely to said insertion.
It is preferred that the conduit comprises a tube having a wall including a portion with a length wise tapered cross-sectional area. The cross-sectional perimeter of a portion of the tube can be tapered in a length wise direction. The cross-sectional area of a portion of the lumen defined by the tube can taper in a length wise direction. It is preferred that the cross-sectional area of the tube wall tapers towards an open end of the tube located within the repository. The open end can be in the form of an annular knife edge. Alternatively, the tube can be sealed to the repository excepting an opening, or openings, in its wall. Thus, when the conduit is forced downwards on the powdered material, the powdered material is more easily displaced, resulting in easy insertion of the conduit when the apparatus is in the upright position.
In a preferred embodiment the apparatus is arranged for the delivery of powdered material into a nasal cavity, this is preferably possible wherein the outlet forms a nozzle for insertion into a nostril. In a further preferred embodiment the conduit is a dip tube.
Apparatus in accordance with the invention may dispense powdered material for the treatment of a medical condition, preferably for the treatment of allergic rhinitis or asthma and preferably wherein the powdered material is hydroxypropylmethylcellulose .
A further aspect of the invention is a conduit for use in the apparatus as described above.
In a yet further aspect of the present invention, there is provided a dip tube for use in apparatus for dispensing a restricted amount of powdered material, wherein the dip tube is arranged for length wise insertion into a repository and to displace powdered material from its path transversely to said insertion.
It is preferred that the dip tube comprises a tube having a wall including a portion with a length wise tapered cross-sectional area. The cross-sectional perimeter of a portion of the tube can be tapered in a length wise direction. The cross-sectional area of a portion of the lumen defined by the tube can taper in a length wise direction. It is preferred that the cross-sectional area of the tube wall tapers towards an open end of the tube located within the repository. The open end can be in the form of an annular knife. Alternatively, the tube can be sealed to the repository excepting an opening, or openings, in its wall.
In a preferred embodiment of the invention a dip tube is arranged for the delivery of powdered material into a nasal cavity, this is preferably possible wherein the outlet forms a nozzle for insertion into a nostril.
A dip tube in accordance with the invention may dispense powdered material for the treatment of a medical condition, preferably for the treatment of allergic rhinitis or asthma wherein the powdered material is preferably hydroxypropylmethylcellulose . An example of an apparatus according to the present invention will now be described, by way of example only, and will make reference to the following drawings.
Figure 1 shows a side plan view (side B), and section thereof (side A), of a nasal delivery apparatus in accordance with the invention;
Figure 2 shows a side plan view (side A), and sectional view thereof (side B), of a dip tube in accordance with the invention;
Figure 3 shows a side plan view (side A), and a sectional view thereof (side B), of a dip tube in accordance with the invention;
Figure 4 shows a side plan view (side A), and a sectional view thereof (side B), of a dip tube in accordance with the invention.
Apparatus in accordance with the invention is shown in Figure 1 and comprises a cap 1 and a bottle 2, formed from a thermal plastic material such as polyvinylchloride, housing a dip tube 3, and provides a repository for a quantity of powdered material 4. The cylindrical bottle 2 comprises a substantially cylindrical body portion 5, extending between a first end portion 6 and shoulder portion 7. The first end portion 6 defines a flat closed disc end base of the bottle 2. The bottle also comprises a neck portion 8, extending between the shoulder portion 7 and the second end portion 12 which defines an opening. A first annular flange 9 extends radially outward from the neck portion 8 of the cylindrical bottle 2 and is releaseably sealed with a second annular flange 10 disposed on the cap 1, to form in use, a tamper proof safety seal as would be readily known to a man skilled in the art. A first screw thread 11 commences at the first annular flange 9 and extends around and partway along the neck portion 8 of the cylindrical bottle 2 in the direction of the second end portion 12. The dip tube 3 is inserted into the internal cavity 13 of the bottle 2 through the opening defined by the second end portion 12, sealing said opening defined by the second end portion 12 by acting as a stopper for the bottle. The dip tube 3 comprises a hollow tube with a first opening 14 at one end, opening into the internal cavity 13. The rim 15 defining the first opening 14 abuts with, or substantially abuts with, the internal surface of the first end portion 6. A castellation 16 defines a notch in the side wall of the dip tube 3, said notch defined by the castellation being continuous with the first opening 14. At the opposite end of the first opening 14 of the dip tube 3 is the second opening 17. The second opening 17 is disposed at the tip of the nozzle portion 18 of the dip tube 3. The nozzle portion 18 is a narrowed portion of the dip tube 3 such that it is dimentioned to fit up a nostril. The dip tube 3 has a radial protrusion 21 which fits inside an indentation on the inner surface of the neck portion 8 of the bottle 2 to form a friction fit. A further radial protrusion 20 on the dip tube 3 sits on top of the bottle neck to seal the bottle.
The cap 1 is shaped such that it may releasably retain the neck portion 8 and nozzle 18 within the cavity 23 when the devise is not in use. When not in use, first screw thread 11, co-operates with second screw thread 24, which is disposed on the internal surface of the cap 1. The cap 1 has a friction surface 25 extending around a portion of external surface of the cap, for ease of rotation between opposing fingers during the operation of removing the cap 1 from the bottle 2.
Figure 2 shows a preferred embodiment of the dip tube 3. Side B of the dotted line shows a section through the dip tube 3. The dip tube 3 has a lumen 26 linking the first 14 and second 17 openings. The inner wall 27 and outer wall 28 become gradually closer, graduations occur in the portion of the dip tube 3 that is disposed within the body portion 5 of the bottle 2. This narrowing of the width of the wall results in a gradual reduction in the diameter of the dip tube 2 and an increase in the diameter of the lumen 26 within the dip tube 2. The narrowest point of the tapering portion 22 defines the first opening 14. At this point the inner wall and the outer wall meet to form the rim 15 of the first opening 14. The sectional profile of the rim 15 being rounded. In an alternative embodiment as shown in Figure 3 the inner and outer walls taper to the first opening 14 with an inner wall 27 and outer wall 28 meeting to form a sharp point at the rim 15 in sectioned profile.
In a further alternative embodiment, as shown in Figure 4, the end of the tip tube 3, to be located in the internal cavity 13, is formed as if cut at an acute angle to the tube's axis and sealed with an eliptical end plate 29. A first opening 14 is formed in the side wall of the dip tube 3 adjacent to the plate 29.
In use, the cylindrical bottle 2 is filled with powered material 4. A user should place the nozzle 18 defining the second end portion 12 of the dip tube 3 into a nostril and then squeeze the body portion 5 between opposing fingers. The compression of the body portion 5 reduces the volume of the cylindrical bottle 2, thereby increasing internal pressure relative to atmospheric pressure. This results in a proportion of the air within the cylindrical bottle flowing down the pressure gradient and finding an exit by travelling through the castellation 16, up through the lumen 26 of the dip tube 3 and exiting at the second opening 17 into the nostril. As the air flows through the apparatus, particles of the powered material 4 will become entrained therein. The limited volume of the powder 4 that is capable of passage through castellation 16 whilst entrained in the air flow will be delivered to the nasal cavity. The pressure gradient will be transient, as equilibrium will be re-established rapidly. The transience of the air flow combined with the fact that the castellation 16 limits the amount of powered material 4 that is given passage to the lumen 26, results in a regulation of the powered material 4 that is capable of expulsion from the apparatus during a single compression of the body portion 5.

Claims

Claims
1. Apparatus for dispensing a restricted amount of powdered material, comprising a repository for powdered material, an outlet and a passageway defined between the repository and the outlet, wherein a volume of air can be propelled through powdered material resting in the repository, thereby entraining powdered material, and carry powdered material thus entrained along the passageway and out of the apparatus in an upwardly direction, via the outlet.
2. Apparatus as claimed claim 1, wherein a restriction in the passageway regulates the amount of powdered material delivered.
3. Apparatus as claimed in claim 2, wherein a conduit extends between the repository and the outlet, and defines the restriction.
4. Apparatus as claimed in claim 3, wherein an entrance to the conduit is defined within the repository and said restriction is disposed at said entrance.
5. Apparatus as claimed in claim 4, wherein the restriction is produced by a gap defined between said entrance and a wall of the repository.
6. Apparatus as claimed in claim 5, wherein the conduit comprises a tube with an open end in substantial abutment with a wall of the repository and the restriction is provided by an opening in the wall of said tube.
7. Apparatus as claimed in any of claims 3 to 6 , wherein said opening is in the form of one or more notches in the open end of the tube.
8. Apparatus as claimed in any of claims 3 to 7, wherein the conduit comprises a tube arranged for length wise insertion into the repository and to displace powdered material from its path transversely to said insertion.
9. Apparatus as claimed in any of claims 4 to 8, wherein the conduit comprises a tube having a wall including a portion with a length wise tapered cross- sectional area.
10. Apparatus as claimed in claim 8 or 9, wherein the cross-sectional perimeter of a portion of the tube is tapered in a length wise direction.
11. Apparatus as claimed in claim 9, wherein the cross-sectional area of a portion of the lumen defined by the tube tapers in a length wise direction.
12. Apparatus as claimed in any of claims 9 to 11, wherein the cross-sectional area of the tube wall tapers towards an open end of the tube located within the repository.
13. Apparatus as claimed in claim 12, wherein said open end is in the form of an annular knife edge.
14. Apparatus as claimed in claim 10, wherein the tube is sealed to the repository excepting an opening, or openings, in its wall.
15. Apparatus as claimed in any of the preceding claims, arranged for the delivery of powdered material into a nasal cavity.
16. Apparatus as claimed in claim 15, wherein the outlet forms a nozzle for insertion into a nostril.
17. Apparatus as claimed in any of the preceding claims, wherein the conduit is a dip tube.
18. Apparatus as claimed in all preceding claims wherein the powdered material is for the treatment of a medical condition.
19. Apparatus as claimed in claim 18, wherein the powdered material is for the treatment of allergic rhinitis or asthma.
20. Apparatus as claimed in claim 18 or 19, wherein the powdered material is hydroxypropylmethylcellulose.
21. A conduit for use in the apparatus as claimed in any of the preceding claims.
22. A dip tube for use in apparatus for dispensing a restricted amount of powdered material, wherein the dip tube is arranged for length wise insertion into a repository and to displace powdered material from its path transversely to said insertion.
23. A dip tube as claimed in claim 22, wherein the dip tube comprises a tube having a wall including a portion with a length wise tapered cross-sectional area.
24. A dip tube as claimed in claim 22 or 23 , wherein the cross-sectional perimeter of a portion of the tube is tapered in a length wise direction.
25. A dip tube as claimed in claim 23, wherein the cross-sectional area of a portion of the lumen defined by the tube tapers in a length wise direction.
26. A dip tube as claimed in any of claims 23-25, wherein the cross-sectional area of the tube wall tapers towards an open end of the tube located within the repository.
27. A dip tube as claimed in claim 26, wherein said open end is in the form of an annular knife edge.
28. A dip tube as claimed in claim 24, wherein the tube is sealed to the repository excepting an opening, or openings, in its wall.
29. A dip tube as claimed in any of claims 22 to 28, arranged for the delivery of powdered material into a nasal cavity.
30. A dip tube as claimed in claim 29, wherein the outlet forms a nozzle for insertion into a nostril.
31. A dip tube as claimed in any of claims 22 to 30, wherein the powdered material is for the treatment of a medical condition.
32. A dip tube as claimed in claim 31, wherein the powdered material is for the treatment of allergic rhinitis or asthma.
33. A dip tube as claimed in any of claims 31 or 32, wherein the powdered material is hydroxypropylmethylcellulose.
34. Apparatus substantially as hereinbefore described with reference to the figures.
35. A dip tube substantially as hereinbefore described with reference to the figures.
PCT/GB2002/000553 2001-02-08 2002-02-08 Apparatus for dispensing powdered material WO2002062416A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP02711035A EP1368090B1 (en) 2001-02-08 2002-02-08 Apparatus for dispensing powdered material
US10/467,773 US7465287B2 (en) 2001-02-08 2002-02-08 Apparatus for dispensing powdered material
DE60219442T DE60219442T2 (en) 2001-02-08 2002-02-08 DEVICE FOR DISPENSING POWDER MATERIAL

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0103172.3 2001-02-08
GB0103172A GB0103172D0 (en) 2001-02-08 2001-02-08 Apparatus for dispensing powdered material
GB0106789A GB2378176B (en) 2001-02-08 2001-03-19 Apparatus for dispensing powdered material
GB0106789.1 2001-03-19

Publications (1)

Publication Number Publication Date
WO2002062416A1 true WO2002062416A1 (en) 2002-08-15

Family

ID=26245702

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/000553 WO2002062416A1 (en) 2001-02-08 2002-02-08 Apparatus for dispensing powdered material

Country Status (6)

Country Link
US (1) US7465287B2 (en)
EP (1) EP1368090B1 (en)
AT (1) ATE359099T1 (en)
DE (1) DE60219442T2 (en)
ES (1) ES2284831T3 (en)
WO (1) WO2002062416A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1454648A1 (en) * 2003-03-05 2004-09-08 Hitachi Unisia Automotive Ltd. Medicine administering device for nasal cavities
WO2016027075A1 (en) * 2014-08-20 2016-02-25 Nasaleze Patents Ltd Dispensing apparatus
FR3117046A1 (en) * 2020-12-09 2022-06-10 Aptar France Sas Powder dose dispensing device

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102107024B (en) * 2004-03-17 2013-03-20 根茨美公司 Device for delivering powder to wound
US9095603B2 (en) * 2006-04-05 2015-08-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Anti-allergy compositions
US20090145433A1 (en) * 2007-12-08 2009-06-11 Michael James Apparatus for dispensing a powdered composition into the aerodigestive tract
US20090148530A1 (en) * 2007-12-08 2009-06-11 Jamie Koufman Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
KR101378719B1 (en) * 2014-01-24 2014-03-27 (주)연우 Container for discharging powder
US10441761B2 (en) 2016-07-01 2019-10-15 Boston Scientific Scimed, Inc. Delivery devices and methods
EP3568179B1 (en) 2017-01-10 2021-10-27 Boston Scientific Scimed, Inc. Apparatuses for delivering powdered agents
RU195387U1 (en) * 2019-12-05 2020-01-24 Общество с ограниченной ответственностью Компания "Динамика" NOSE INHALATOR
GB202001906D0 (en) 2020-02-12 2020-03-25 Nasaleze Patents Ltd Compositions And Applications Thereof
GB2611803A (en) 2021-10-15 2023-04-19 Nasaleze Patents Ltd Compositions of high viscosity
GB202205231D0 (en) 2022-04-09 2022-05-25 Nasaleze Patents Ltd Vaccine compositions
GB202205769D0 (en) 2022-04-20 2022-06-01 Nasaleze Patents Ltd Compositions and applications therefor

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB627662A (en) * 1947-07-03 1949-08-12 Metal Box Co Ltd Improvements in or relating to containers for inhalants
GB806284A (en) * 1955-11-14 1958-12-23 Chi Ah Lai A new or improved nasal inhaler
FR2628638A1 (en) * 1985-03-06 1989-09-22 Sandoz Lab Medicinal nasal spray - with tapered inner surface to base of flask and tube descending into it from sprayer
US5584417A (en) * 1990-07-04 1996-12-17 Ing. Erich Pfeiffer Gmbh & Co. Kg Dispenser for discharging a fluid medium
US5683361A (en) * 1991-12-10 1997-11-04 Novo Nordisk A/S Disposable dispenser for powder
EP0972533A2 (en) * 1998-07-14 2000-01-19 Ing. Erich Pfeiffer Gmbh Product dispenser

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US464969A (en) * 1891-12-15 Inhaler
US443545A (en) * 1890-12-30 Device for injecting medical powders
US2796294A (en) * 1954-10-15 1957-06-18 Bain L Mckinnon Squeeze bottle nebulizer
US2896825A (en) * 1956-10-15 1959-07-28 William L Jackson Dispensing device
US3100362A (en) * 1961-07-07 1963-08-13 Getz Exterminators Inc Powder distributors
US3241726A (en) * 1964-06-08 1966-03-22 Frank R Chester Resilient valved diaphragm for comminuted material dispenser
US3572590A (en) * 1968-05-31 1971-03-30 Afa Corp Squeeze bottle atomizers and liquid dispensers
US3666182A (en) * 1970-04-24 1972-05-30 Chatten Drug & Chem Co Squeeze bottle with means for locating end of delivery tube
US4015753A (en) * 1976-03-17 1977-04-05 Robert Bennett Dip tube powder spray control device
US4730751A (en) * 1986-05-16 1988-03-15 Leonard Mackles Squeeze bottle powder dispenser
AU703160B2 (en) * 1995-07-25 1999-03-18 Teijin Limited Device for administering powdery medicine
IS4516A (en) * 1997-07-01 1999-01-02 Gizurarson Sveinbjörn New pharmaceutical form
US5971234A (en) * 1998-08-28 1999-10-26 Mathison; Tom Bernard Dust dispensing system for use in squeeze-type dust dispensers

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB627662A (en) * 1947-07-03 1949-08-12 Metal Box Co Ltd Improvements in or relating to containers for inhalants
GB806284A (en) * 1955-11-14 1958-12-23 Chi Ah Lai A new or improved nasal inhaler
FR2628638A1 (en) * 1985-03-06 1989-09-22 Sandoz Lab Medicinal nasal spray - with tapered inner surface to base of flask and tube descending into it from sprayer
US5584417A (en) * 1990-07-04 1996-12-17 Ing. Erich Pfeiffer Gmbh & Co. Kg Dispenser for discharging a fluid medium
US5683361A (en) * 1991-12-10 1997-11-04 Novo Nordisk A/S Disposable dispenser for powder
EP0972533A2 (en) * 1998-07-14 2000-01-19 Ing. Erich Pfeiffer Gmbh Product dispenser

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1454648A1 (en) * 2003-03-05 2004-09-08 Hitachi Unisia Automotive Ltd. Medicine administering device for nasal cavities
US7438700B2 (en) 2003-03-05 2008-10-21 Hitachi, Ltd. Medicine administering device for nasal cavities
WO2016027075A1 (en) * 2014-08-20 2016-02-25 Nasaleze Patents Ltd Dispensing apparatus
FR3117046A1 (en) * 2020-12-09 2022-06-10 Aptar France Sas Powder dose dispensing device
WO2022123128A1 (en) * 2020-12-09 2022-06-16 Aptar France Sas Powder dose dispensing device

Also Published As

Publication number Publication date
US7465287B2 (en) 2008-12-16
EP1368090B1 (en) 2007-04-11
EP1368090A1 (en) 2003-12-10
ATE359099T1 (en) 2007-05-15
DE60219442D1 (en) 2007-05-24
ES2284831T3 (en) 2007-11-16
US20040082907A1 (en) 2004-04-29
DE60219442T2 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
US5568807A (en) Air-flow control for an inhaler
US8109267B2 (en) Simple inhaler
EP1450885B1 (en) Nasal nebulizer
US4570630A (en) Medicament inhalation device
US9352106B2 (en) Particle dispersion device for nasal delivery
US5161524A (en) Dosage inhalator with air flow velocity regulating means
US6644305B2 (en) Nasal inhaler
EP1368090B1 (en) Apparatus for dispensing powdered material
US4227522A (en) Inhalation device
US7032593B2 (en) Inhalation device and method
TW470655B (en) Systems and methods for aerosolizing pharmaceutical formulations
EP1673123A2 (en) Integrated nebulizer and particle dispersing chamber for delivery of medicament
KR20070027691A (en) Dry powder inhaler
GB2378176A (en) Apparatus for dispensing powdered material
JP2004531334A (en) Flow regulator for aerosol drug delivery device and method
EP1311314A2 (en) Nasal inhaler

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10467773

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2002711035

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002711035

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWG Wipo information: grant in national office

Ref document number: 2002711035

Country of ref document: EP